Announced
Financials
Tags
Pending
Pharmaceuticals
Acquisition
Single Bidder
pharmaceuticals company
Friendly
Private Equity
Private
Majority
Egypt
Cross Border
Synopsis
Affirma Capital and StonePine, a private equity firms, agreed to acquire a majority stake in Nerhadou International, a pharmaceutical company, for $20m. “We are pleased to welcome aboard global investors such as Affirma Capital and StonePine to join us on our growth journey. Affirma and StonePine have been hands-on partners and have already helped us identify and execute on several value enhancement initiatives. We believe that their investment in Nerhadou will accelerate the company’s growth plans, solidify its market position, and bring the Company to IPO standards," Mohamed Shalaby, Nerhadou CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.